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Enantiopure sulfoxides are prevalent in drugs and are useful chiral auxiliaries in organic synthesis. The
biocatalytic enantioselective oxidation of prochiral sulfides is a direct and economical approach for the
synthesis of optically pure sulfoxides. The selection of suitable biocatalysts requires rapid and reliable
high-throughput screening methods. Here we present four different methods for detecting sulfoxides produced
via whole-cell biocatalysis, three of which were exploited for high-throughput screening. Fluorescence detection
based on the acid activation of omeprazole was utilized for high-throughput screening of mutant libraries of
toluene monooxygenases, but no active variants have been discovered yet. The second method is based on the
reduction of sulfoxides to sulfides, with the coupled release and measurement of iodine. The availability of
solvent-resistant microtiter plates enabled us to modify the method to a high-throughput format. The third
method, selective inhibition of horse liver alcohol dehydrogenase, was used to rapidly screen highly active
and/or enantioselective variants at position V106 of toluene ortho-monooxygenase in a saturation mutagenesis
library, using methyl-p-tolyl sulfide as the substrate. A success rate of 89% (i.e., 11% false positives) was
obtained, and two new mutants were selected. The fourth method is based on the colorimetric detection of
adrenochrome, a back-titration procedure which measures the concentration of the periodate-sensitive sulfide.
Due to low sensitivity during whole-cell screening, this method was found to be useful only for determining the
presence or absence of sulfoxide in the reaction. The methods described in the present work are simple and
inexpensive and do not require special equipment.
The growing demand for green catalytic processes has in-
creased the utilization of enzymes as industrial biocatalysts for
the synthesis of fine chemicals (6, 19, 20). As a consequence,
there is a continuous search for novel or improved biocatalysts.
In order to find an appropriate candidate for a process, various
sources of enzymes must be screened for activity (23). There-
fore, a sensitive, reproducible, accurate, and simple high-
throughput screening method is a key prerequisite for the
development of biocatalytic processes on an industrial scale
(32, 39).
Screening systems are divided into three different classes.
The first class contains assays applicable to testing growing
or resting microbial colonies for enzymatic activity directly
on agar plates (23), for example, detection of epoxide hy-
drolase activity on butane oxide by use of safranin O. Oxi-
dation of the 1,2-diol product by Escherichia coli modified
the membrane potential and led to accumulation of the red
dye in the colonies producing active enzyme (34). In another
study, the spontaneous oxidation of substituted catechols to
brown-red quinones was used to screen random libraries of
whole cells expressing toluene monooxygenases (TMOs) for
regioselective oxidation of substituted phenols (12, 30). The
positive clones produced a red halo around the cells. These
assays are high-throughput, simple procedures but often
require a tailored substrate with a chromophore, such as
bromonaphthol or azo-dye (23).
The second class includes chromogenic and fluorogenic
assays applicable in microtiter plates or microarray formats
(23). Microtiter plates in 96- or 384-well format are partic-
ularly well suited for spectroscopic reading using either UV-
visible or fluorescence plate readers. This class may be sub-
divided into the following four groups: (i) enzyme-coupled
assays, such as the determination of dehydrogenase activity
through formation of NADH from NAD and an absorbance
change at a wavelength of 340 nm; (ii) assays using chromo-
genic and fluorogenic substrates, such as various syntheti-
cally labeled substrates that are commercially available for
the determination of hydrolytic activity produced by lipases,
phosphatases, glycosidases, amidases, etc.; (iii) assays using
chromogenic and fluorogenic sensors, such as widely used
pH indicators (16), that may be applied in any reaction that
includes a change in pH; and (iv) microarray assays using a
solid support, enabling screening of thousands of samples.
The high-throughput potential of these methods was dem-
onstrated by profiling of 40 different esterases and lipases
across 35 different fluorogenic ester substrates, using only 50
l of each enzyme solution and a submilligram quantity of
each substrate for over 7,000 tests (2).
The third class of enzymatic assays rely on product detection
by instruments and include gas chromatography (GC), high-
pressure liquid chromatography (HPLC), mass spectrometry,
nuclear magnetic resonance (NMR) spectrometry, and infra-
red radiation assays that have been adapted for high through-
put (22, 23, 33). Such assays require expensive and sophisti-
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cated equipment, but they allow working directly with the
substrate of interest and are rapidly adapted once the instru-
ment is available (23).
Various chemical substances can be synthesized by bacteria
and fungi, among which are the chiral sulfoxides (5, 10, 11, 24,
36). As natural products, chiral sulfoxides possess a wide range
of biological activities, from flavor and aroma precursor activ-
ities to antimicrobial properties. In addition, they are efficient
auxiliaries that lead to essential asymmetric transformations
(3, 11). Furthermore, one of the most significant applications
of chiral sulfoxides is in the pharmaceutical industry (3). The
world’s best-selling antiulcer drug, (S)-omeprazole, is a chiral
sulfoxide (11, 14). Although there have been numerous reports
on chemical and biological methods for synthesizing chiral
sulfoxides, little information exists about rapid high-through-
put assays for sulfoxide determination. In this study, four col-
orimetric or fluorometric procedures were evaluated and
adapted for screening of whole-cell libraries containing vari-
ants of TMOs. Three of the four methods were exploited
successfully to a high-throughput format using 96-well micro-
titer plates, whereas one method was not suitable due to low
sensitivity. The method based on acid activation of omeprazole
proved very efficient, but no positive variants were found, whereas
the one based on selective inhibition of horse liver alcohol dehy-
drogenase (HLADH), originally reported by Sprout and Seto
(28), was useful for detecting mutants with high activity and en-
antioselectivity in the oxidation of methyl p-tolyl sulfide.
MATERIALS AND METHODS
Chemicals. Thioanisole (methyl phenyl sulfide; 99%), methyl p-tolyl sulfide
(99%), methyl phenyl sulfoxide (97%), (R)- and (S)-methyl p-tolyl sulfoxide
(98%), liver acetone powder (LAP; originated from horse), -NAD, and adren-
aline hydrochlorate were purchased from Sigma-Aldrich (Rehovot, Israel). So-
dium meta-periodate and hydrochloric acid were purchased from Merck (Darm-
stadt, Germany). Trifluoroacetic acid anhydride (TFAA) was purchased from
Riedel-de Hae¨n (Seezle, Germany). Sodium iodide was purchased from Spec-
trum (New Brunswick, NJ). Omeprazole-sulfide was received from the TAMI-
IMI Institute for R&D (Haifa, Israel). (S)-Omeprazole was obtained from Teva
(Petach-Tikva, Israel). All materials used were of the highest purity available and
were used without further purification.
Bacterial strains and growth conditions. Escherichia coli TG1 (supE hsd5 thi
(lac-proAB) F [traD36 proAB lacIq lacZM15]) carrying plasmid constructs
was routinely cultivated at 37°C with shaking at 250 rpm in a TU-400 incubator
shaker (orbital shaker incubator; MRC, Holon, Israel) in Luria-Bertani (LB)
medium (26) supplemented with kanamycin at 100 g/ml (LBK) to maintain the
plasmids. To stably and constitutively express the TMO genes from the same
promoter, the expression vectors pBS(Kan)TOM (7), pBS(Kan)TpMO (31),
pBS(Kan)ToMO (35), and pBS(Kan)T4MO (31) were constructed as described
earlier. Expression of TMOs (wild type [WT] and protein variants) by pBS(Kan)
vectors within E. coli strains produced blue or brown colonies on agar plates and
in broth cultures. The color is indicative of indigoid compounds formed by the
oxidation of indole from tryptophan (9, 25).
Screening methods. (i) Fluorescence test for omeprazole. Screening for mu-
tants with improved activity was performed by picking colonies from glycerol
stocks stored in 96-well plates, using a VP 381 library copier (V&P Scientific,
Inc., San Diego, CA), and transferring them to 96-deep-well plates with plastic
lids (ABgene; Thermo Fisher Scientific, Epson, United Kingdom) containing 1.2
ml of LBK per well. The cells were grown for 18 h at 37°C with shaking at 250
rpm in a TU-400 incubator shaker, followed by centrifugation at 3,000  g for 10
min at 25°C, using a Sigma 4K15 centrifuge (Sigma, Osterode, Germany). The
cell pellets were resuspended in 350 l of 20 mM phosphate buffer (PB), pH 7,
and then 100 l was removed to measure the cell density (optical density [OD]
at 600 nm, 1.1). The substrate omeprazole-sulfide was added to 250 l of
bacterial suspension to a final concentration of 0.25 mM (from a 12.5 mM stock
solution in ethanol), and the biotransformation was carried out for 48 h with
shaking at 600 rpm, using a Vibramax 100 shaker (Heidolph, Nurenberg, Ger-
many), at 25°C. The reaction was stopped by additional centrifugation at 3,000 
g for 10 min at 25°C. One hundred microliters of the supernatant was transferred
to F96 MicroWell black microtiter plates (Nunc, Roskilde, Denmark). Thirty
microliters of 0.1 N HCl was added to each well. The plate was incubated for 5
min at room temperature, and the fluorescence signal was measured (excitation
wavelength, 370 nm; emission wavelength, 560 nm) using a Synergy HT multi-
plate reader (BioTek Instruments, VT). All liquid handling steps were conducted
using an epMotion 5070 robotic system (Eppendorf AG, Hamburg, Germany).
(ii) Adrenaline test. Omeprazole-sulfide, thioanisole, and methyl-p-tolyl sul-
fide were examined as potential substrates in the adrenaline test. The procedure
included bacterial growth in 5 ml LBK for 20 h at 37°C with shaking at 250 rpm
(TU-400 incubator shaker), followed by cell harvesting at 8,000  g for 10 min
at 25°C (Sigma 4K15 centrifuge). The cell pellets were resuspended in 2.5 ml of
20 mM PB, pH 7, to a final OD of 4. The substrates were added (0.5 mM
substrate from a 50 mM stock solution in ethanol) to 1 ml of cell suspension, and
the biotransformation was carried out for 3 h in a 16-ml glass vial with shaking
at 600 rpm, using a Vibramax 100 shaker, at 25°C. The reaction was stopped by
centrifugation (13,400  g for 1 min), using a Minispin centrifuge (Eppendorf,
Hamburg, Germany). Eight hundred fifty microliters of the supernatant was
transferred to a new vial and then incubated with 50 l NaIO4 (10 mM stock in
water) for 20 min. Subsequently, 150 l of adrenaline-hydrochloride (15 mM
stock in water) was added and incubated for 5 min, followed by measurement of
color at 490 nm (Ultrospec 2100 Pro; Amersham Biosciences, Uppsala, Sweden).
The total assay volume was 1,050 l.
(iii) TFAA-NaI test. Bacterial growth was performed as described for the
fluorescence test. The growth was followed by centrifugation at 3,000  g for 10
min at 25°C, using a Sigma 4K15 centrifuge (Sigma, Osterode, Germany). The
cell pellets were resuspended in 600 l of 0.1 M PB, pH 7, and then 100 l was
removed to measure the cell density (OD at 600 nm, 1). The substrate, methyl
phenyl sulfide, was added to 500 l of bacterial suspension to a final concentra-
tion of 1 mM (from a 50 mM stock solution in ethanol), and the biotransforma-
tion was carried out for 5 h with shaking at 750 rpm, using a Vibramax 100 shaker
(Heidolph, Nurenberg, Germany), at 25°C. The reaction was stopped by addi-
tional centrifugation at 3,000  g for 10 min at 25°C. Four hundred microliters
of the supernatant was transferred to a new polypropylene deep-well plate
(ABgene; Thermo Fisher Scientific, Epson, United Kingdom), and 400 l of
ethyl acetate was added to each well (1:1 [vol/vol]) for the extraction of reactants.
After vigorous pipetting of the reaction mixture, phase separation was facilitated
by an additional centrifugation step (3,000  g for 10 min), and 100 l of the
organic phase was transferred to a new polypropylene 96-well plate (Grenier)
with a flat bottom (Sigma-Aldrich, Rehovot, Israel). TFAA (10 l from a 0.5 M
stock in acetone) and sodium iodide (NaI) (100 l from a 0.5 M stock in acetone)
were added, followed by vigorous pipetting and a 2-min incubation at room
temperature. The total assay volume was 210 l. Determination of the amount
of iodine released during the reduction reaction was measured at 362 nm in a
multiplate reader (Molecular Devices, Sunnyvale, CA).
(iv) Selective inhibition of HLADH. Bacterial growth conditions were as
described for the fluorescence test, utilizing a VP 381 library copier and an
epMotion 5070 liquid handling system. The cell pellets were resuspended in
350 l of 46 mM sodium phosphate buffer, pH 7, to a final OD of 1.1. The
substrate methyl p-tolyl sulfide was added to 250 l of bacterial suspension
(100 l of the suspension was utilized for OD measurement) to a final
concentration of 1 mM (from a 50 mM stock solution in ethanol), and the
biotransformation was carried out for 4 h with shaking at 600 rpm, using a
Vibramax 100 shaker, at 25°C. The reaction was stopped by additional cen-
trifugation at 3,000  g for 10 min at 25°C, using a Sigma 4K15 centrifuge.
Ninety microliters of supernatant from each well was transferred to a new
96-well polystyrene plate (Nunc, Roskilde, Denmark). Ten microliters of
freshly prepared LAP solution (from a 10-mg/ml filtered stock solution in 46
mM ice-cold sodium phosphate buffer, pH 7) was added. The reaction was
initiated by adding 90 l of freshly prepared 100 mM ethanol and 30 mM
-NAD in 46 mM ice-cold sodium phosphate buffer, pH 7. The total assay
volume was 190 l. Absorbance data at a wavelength of 340 nm were col-
lected over a period of 180 min, using a multiplate reader (Molecular De-
vices, Sunnyvale, CA).
Validation methods. In order to confirm the accuracy and reproducibility of
the screening methods, examined variants were also analyzed using GC or HPLC
analysis. The bacteria were grown as described in the screening method section,
and after biotransformation the supernatant was designated either for screening
or for GC/HPLC analysis.
Analytical methods. Conversion of thioanisole and methyl p-tolyl sulfide to the
corresponding sulfoxides was determined with a GC 6890N instrument (Agilent
Technologies, Santa Clara, CA), using a 30-m by 0.32-mm by 0.25-m capillary
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column packed with -cyclodextrin trifluoroacetyl (Chiraldex G-TA; ASTEC,
Bellefonte, PA) and a flame ionization detector. The temperature for thioanisole
was programmed as follows: T1 	 110°C (dT/dt 	 10°C/min), T2 	 130°C (dT/dt
	 20°C/min), and T3 	 160°C (13 min), with a split ratio of 1:3. Under these
conditions, the retention times were 3.89 min for thioanisole, 10.35 min for (R)-
methyl phenyl sulfoxide, and 14.15 min for (S)-methyl phenyl sulfoxide. For deter-
mination of methyl p-tolyl sulfide conversion, the temperature was programmed
as follows: T1 	 110°C (dT/dt 	 10°C/min), T2 	 130°C (dT/dt 	 20°C/min), and
T3 	 160°C (17.5 min), with a split ratio of 1:3. Under these conditions, the
retention times were 4.45 min for methyl p-tolyl-sulfide, 12.56 min for (R)-methyl
p-tolyl sulfoxide, and 13.46 min for (S)-methyl p-tolyl sulfoxide.
For the oxidation of omeprazole-sulfide to esomeprazole, an HPLC method
was developed with an Agilent 1100-series instrument (Agilent Technologies,
Santa Clara, CA) using an Eclipse XDB C18 column (5 m, 4.6 by 150 mm;
Agilent Technologies). The samples were diluted in H2O-acetonitrile (75%–
25%) and filtered using a 0.45-m polyvinyl difluoride filter (Millex HV; Milli-
pore, Cork, Ireland). The mobile phase was set as 70%–30% H2O-acetonitrile
for 0 to 1 min, with a gradient to 40%–60% H2O-acetonitrile at 6 min and a
gradient to 70%–30% H2O-acetonitrile at 12 min, and the flow rate was 1
ml/min. Compounds were identified by comparison of retention times (omepra-
zole-sulfide retention time, 7.1 min; esomeprazole retention time, 4.8 min) and
UV-visible spectra to those of authentic standards. Calibration curves were made
at the maximum wavelength of both compounds (300 nm).
Saturation mutagenesis. Saturation mutagenesis at position TmoA I100 in
pBS(Kan)T4MO and TomA3 V106 in pBS(Kan)TOM was described by Feinger-
sch et al. (10). A gene library encoding all possible amino acids at position 285
of T4MO TmoA in pBS(Kan)T4MO was constructed by replacing the target
codon with NNN (N stands for A, T, G, or C) via overlap extension PCR. Two
primers, BM_T4MO_285_Front and T4MO_285_Rear (Table 1), were designed
to randomize position 285 of TmoA. Two additional primers for cloning of each
enzyme were T4MObefEcoRI Front and T4MOABRear (Table 1). Vent DNA
polymerase (New England Biolabs, Ipswich, MA) was used in the PCR to
minimize random point mutations, and pBS(Kan)T4MO was used as the tem-
plate. The first, 1,006-nucleotide degenerate fragment was amplified by PCR
using two primers, T4MObefEcoRI Front and T4MO_285_Rear, and the second
degenerate fragment (1,062 nucleotides) was amplified by PCR using two other
primers, T4MO_285_Front and T4MOABRear. The PCR program consisted of
an initial denaturation at 94°C for 2 min, followed by 25 cycles of 94°C for 45 s,
55°C for 45 s, and 72°C for 2.2 min, with a final extension at 72°C for 8 min. The
two fragments were combined at a 1:1 ratio as templates to obtain the full-length
degenerate PCR product (2,034 bp), using T4MObefEcoRI Front and
T4MOABRear as primers. The PCR program was programmed as follows: initial
denaturation at 94°C for 2 min, followed by 25 cycles of 94°C for 45 s, 55°C for
45 s, and 72°C for 3.15 min, with a final extension at 72°C for 8 min. The resulting
PCR product, containing randomized nucleotides at TmoA position 285, was
cloned into pBS(Kan)T4MO after double digestion with EcoRI and AatII, re-
placing the corresponding fragment in the original plasmid. The AatII site occurs
naturally within the tmoC gene and the EcoRI site is upstream of tmoA in the
multiple cloning site. The resulting plasmid library was transformed into E. coli
TG1 competent cells via electroporation using a MicroPulser electroporator
(Bio-Rad, Hercules, CA).
Random mutagenesis via epPCR. The tmoA and tmoB genes, encoding 
 and
 hydroxylase subunits, respectively, and 20% of the tmoC gene (1,936 bp) in
pBS(Kan)T4MO were amplified using error-prone PCR (epPCR). The 100-l
reaction mixture contained 67 mM Tris-HCl (pH 8.8 at 25°C), 16 mM
(NH4)2SO4, 0.01% Tween 20, 5 mM MgCl2, 0.35 mM MnCl2, 1 M betaine, 40 ng
of template DNA [pBS(Kan)T4MO], a 0.2 mM concentration of dATP and
dGTP, a 1 mM concentration of dCTP and dTTP, 5 U of Taq DNA polymerase
(Bioline; Biotaq, London, United Kingdom), and 30 pmol of each primer
(T4MObefEcoRI Front and T4MOABRear) (Table 1). The T4MObefEcoRI
Front primer is targeted upstream of the EcoRI restriction site, located in the
multiple cloning site, and the T4MOABRear primer is targeted downstream of
the naturally occurring AatII site within the tmoC gene.
The tomA3 and tomA4 genes, encoding 
 and  hydroxylase subunits,
respectively, in pBS(Kan)TOM (2,128 bp) were amplified using epPCR with
the same conditions, but with primers TOM_FRONT_ep_np and TOM_
Rear_ep_np (Table 1). The TOM_FRONT_ep_np primer is targeted up-
stream of the BlpI restriction site, and the TOM_Rear_ep_np primer is
targeted downstream of the MfeI restriction site. The PCR program used for
DNA amplification consisted of initial denaturation at 94°C for 2 min, fol-
lowed by 30 cycles of 94°C for 1 min, 59.3°C or 58.3°C (for T4MO or TOM,
respectively) for 1 min, and 72°C for 2.5 min, with a final extension at 72°C
for 7 min. The resulting randomized PCR products were cloned into
pBS(Kan)T4MO or pBS(Kan)TOM after double digestion with AatII and
EcoRI or BlpI and MfeI (New England Biolabs, Beverly, MA), respectively,
replacing the corresponding fragment in the original plasmid. The resulting
plasmid library was transformed into E. coli TG1 competent cells via elec-
troporation, using a MicroPulser electroporator.
RESULTS
(i) Fluorescence assay for omeprazole. The production of
omeprazole from omeprazole-sulfide was based on the acid
activation of omeprazole, which results in the development of
a fluorescent signal at an excitation wavelength of 370 nm, with
emission at 560 nm (29) (Fig. 1a). Under the experimental
conditions used, omeprazole-sulfide remains inactivated and
does not interfere with the fluorescence signal (Fig. 2a). A
calibration curve prepared with buffer containing increasing
concentrations of omeprazole was linear with the fluorescence
signal, indicating that the presence of omeprazole in the reac-
tion mixture could be detected using this method (Fig. 2b). In
order to establish optimal conditions for the assay, several
parameters were examined, including sample volume, assay
TABLE 1. Primers used for random mutagenesis via epPCR, for sequencing of tmoA and tmoB in TG1/pBS(Kan)T4MO and tomA3 and
tomA4 in TG1/pBS(Kan)TOM, and for saturation mutagenesis at position D285 in the tmoA gene in TG1/pBS(Kan)T4MO
Primer Nucleotide sequence (5–3)
Mutagenesis primers
T4MObefEcoRI Front .....................................................................................................CCATGATTACGCCAAGCGCG
T4MOABRear...................................................................................................................TCCATGCTCTTCACTGTTGAC
BM_T4MO_285_Front.....................................................................................................GGATTACTACACGCCGTTGGAGNNNCGCAGCCAG
T4MO_285_Rear ..............................................................................................................AACTCCTTGAATGACTGGCTGCGNNNCTCCAACGG
TOM_FRONT_ep_np......................................................................................................CTCCAGCAAATCCACATCAACC
TOM_REAR_ep_np ........................................................................................................GGGGCTGAATGTTGAGTTGATAGG
Sequencing primers
T4MObefEcoRI Front .....................................................................................................CCATGATTACGCCAAGCGCG
T4MO Seq1 .......................................................................................................................CCCGCATGAATACTGTAAGAAGGATCGC
T4MO Seq2 .......................................................................................................................GCTCGTTGATAGATCTGGGCTTGGAC
T4MO Seq3 .......................................................................................................................AATCTATTGAAGAGATGGGCAAAGACGC
TOM_FRONT_ep_np......................................................................................................CTCCAGCAAATCCACATCAACC
TOM_BSIWI_FRONT (TOM1) ....................................................................................CCGATGGAGAAAGTGTTTCCGTACGAC
TOM Seq 3........................................................................................................................CGCCACATGACACTCGGCATC
TOM seq 4.........................................................................................................................CGGCGACAAGTATCACTTCTGC
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medium (LBK or PB), ionic strength of the biotransformation
buffer, and the pH of the sample, adjusted with HCl (Fig. 2a).
Eventually, this technique was modified for high-throughput
screening of bacterial libraries in 96-well microtiter plates,
using the epMotion 5070 liquid handling system. The process
involves bacterial growth and biotransformation in 96-deep-
well plates, transfer of the supernatant to F96 MicroWell black
microtiter plates, and the addition of HCl, followed by incu-
bation for 5 min and fluorescence measurement using a mul-
tiplate reader. The use of LBK medium for the biotransfor-
mation resulted in a high fluorescence signal and interfered
with the results (Fig. 2a); therefore, the biotransformation was
performed in buffer and the cells were removed prior to the
addition of HCl. PB at an ionic strength of 100 mM was
FIG. 1. Chemical reactions used to detect sulfoxides in this study. (a) Fluorescence-based assay for direct measurement of the omeprazole-HCl
complex. (b) Adrenaline-based assay for measurement of the remaining sulfide in the reaction. (Adapted from reference 38.) (c) TFAA-NaI
reagent for the reduction of sulfoxide and liberation of I2. (d) Selective inhibition of horse LAP by methyl p-tolyl sulfoxide. (Adapted from
reference 28.)
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inappropriate for the assay (results not shown), but 20 mM was
adequate, as depicted for the control sample (Fig. 2a). The
optimal pH for the reaction was determined to be 2.
Random libraries of T4MO and TOM were prepared using
epPCR, as were three saturation mutagenesis libraries for po-
sitions TOM V106 and T4MO I100 and D285. Residue V106
in TOM and the analogous position, I100, in T4MO were
shown in previous works to influence regio- and enantioselec-
tivity and were therefore prime targets here. For instance,
T4MO I100A and I100S mutants were highly active in the
hydroxylation of nitrobenzene (12), whereas an I100G mutant
oxidized methyl para-tolyl sulfide 11 times faster than the WT
and changed the selectivity from 41% pro-R to 77% pro-S (10).
TOM V106A had increased activity on various chlorinated
ethenes (7) as well as improved enantioselectivity on thioani-
sole (10). T4MO D285 is situated near the protein surface in
the entrance to the active site channel and was chosen based
on homology modeling studies (unpublished results). This pre-
viously unstudied position is suggested to control substrate
entrance and product efflux. Thousands of colonies from these
libraries were screened using the high-throughput method de-
scribed above; however, no active variants on omeprazole-
sulfide were found.
An attempt was made to apply the fluorescence test of omep-
razole for detection of additional sulfoxides, such as methyl
phenyl sulfoxide and methyl p-tolyl sulfoxide; however, there
was no difference between the signals of the sulfides and their
corresponding sulfoxides. Thus, this assay is specific for omep-
razole.
(ii) Adrenaline test. The adrenaline test is a back-titration
procedure which measures the concentration of periodate-sen-
sitive substances (38). In the original publications, diols and
epoxides were used as substrates (37, 38). In the present TMO-
catalyzed reaction, sulfoxide was produced using whole cells,
and the remaining sulfide was oxidized with excess sodium
periodate, followed by reaction of the remaining periodate
with adrenaline to form the red dye adrenochrome (Fig. 1b). It
is expected that the more sulfoxide is produced by the cells, the
more intense the red color will be (less sulfide remains, and
therefore more sodium periodate oxidizes adrenaline and
more adrenochrome is created). Various parameters were
evaluated during the development of the adrenaline test, in-
cluding substrate concentration, incubation times with NaIO4
and adrenaline-hydrochloride, ionic strength of pH 7.0 PB, and
concentration of NaIO4. It was found that the reaction cannot
be performed with LBK medium, since no color appears, per-
haps due to oxidation by sodium periodate of other substances
present in the medium, such as glycerol (13). Additionally, it
was found that the ionic strength of PB influences the absor-
bance (the absorbance is higher when 20 mM PB is used than
when 100 mM PB is used). Finally, it was discovered that the
presence of cells interferes with absorbance measurement;
therefore, an additional centrifugation step is needed to obtain
cell-free medium (results not shown).
The following three sulfides and their respective sulfoxides
were examined using the adrenaline test: methyl phenyl sulfide
and methyl phenyl sulfoxide, methyl-p-tolyl sulfide and (S)-
and (R)-methyl-p-tolyl-sulfoxide, and omeprazole-sulfide and
esomeprazole. Methyl phenyl sulfide and methyl p-tolyl sulfide
and their corresponding sulfoxides showed good correlations
between absorbance at 490 nm and increasing sulfoxide con-
centrations (Fig. 3). But when the method was tested on WT
TMOs and their variants, the results did not correlate with
those of GC, making this assay not sensitive enough for eval-
uation of highly active mutants. In addition, omeprazole
showed no correlation between color intensity and sulfoxide
concentration (Fig. 3); hence, this method was found to be
inappropriate as a high-throughput screening exam.
(iii) TFAA-NaI test. The TFAA-NaI method is based on
the use of a TFAA-NaI mixture as a reducing agent, con-
FIG. 2. Fluorescence-based assay for direct measurement of HCl-activated omeprazole. (a) Fluorescent signals of different treated samples of
omeprazole and omeprazole-sulfide (total concentration of 0.5 mM). Samples including cells and standards in LBK or 20 mM PB were centrifuged,
and the supernatant was examined for fluorescence after activation with 1 N HCl. (b) Calibration curve of omeprazole in 20 mM PB, obtained from
the multiplate reader at an excitation wavelength of 370 nm and an emission wavelength of 560 nm. Every bar in the graph represents at least three
independent experiments (the total concentration of substrate and product was 0.5 mM).
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verting sulfoxides to the corresponding sulfides, followed by
the release of iodine, whose yellow color is measured at 362
nm (17) (Fig. 1c). There is a direct correlation between
sulfoxide production and the intensity of the yellow color.
Originally, this method was developed for determination of
chemically synthesized S-oxo and N-oxo compounds (17),
and we modified it for determination of microbial sulfoxi-
dation reactions. The bacterial oxidation of methyl phenyl
sulfide to methyl phenyl sulfoxide was used as a model
reaction. The original protocol used acetone as a medium,
but this solvent did not extract the substrate and the product
well and was found to damage 96-well polystyrene plates. A
mixture of glacial acetic acid and acetic anhydride (95:5
[vol/vol]) was compatible with the plates, but it provided a
very intense yellow color which limited absorbance reading
without massive dilution of the samples. The liberated io-
dine could only be determined by an additional step of back
titration with sodium thiosulfate, using starch as an indica-
tor. The use of pH 7 PB as a reaction medium was examined
at different ionic strengths (20 mM and 100 mM), but there
was insufficient correlation between the color intensity and
sulfoxide concentrations, and a long incubation time (80
min) was required. Therefore, it was concluded that an
organic solvent is necessary for the TFAA-NaI reaction.
Acetone was replaced with ethyl acetate due its superior
extraction of methyl phenyl sulfide and methyl phenyl sul-
foxide following biotransformation. In addition, different
concentrations and ratios of TFAA and NaI were examined
(15 to 100 mM and 0.15 to 1 M, respectively). Eventually,
the procedure consisted of 400 l ethyl acetate as an extrac-
tant, 20 mM TFAA, and 0.2 M NaI, with an incubation time
of 2 min and measurement of the absorbance at 362 nm. A
linear correlation between sulfoxide concentration and ab-
sorbance was obtained using the method developed (results
not shown). Upon testing of the method on whole cells
expressing TMOs, it was discovered that a second centrifu-
gation step is necessary to remove the cells prior to contact
with ethyl acetate in order to prevent the extraction of
interfering indigoid colors present in the cells. Since the
assay is performed with organic medium, it cannot be exe-
cuted in 96-well polystyrene plates. Recently, solvent-resis-
tant 96-well plates (made from polypropylene) were mar-
keted by Sigma-Aldrich, enabling us to exploit this simple
and sensitive method in a high-throughput format. The final
version of the assay showed a high correlation with GC
FIG. 3. Adrenaline-based assay for measurement of the remaining
sulfide in the biotransformation reaction. Calibration curves created
with 20 mM PB (without the presence of cells) are presented for
methyl phenyl sulfoxide, methyl p-tolyl sulfoxide, and omeprazole at a
wavelength of 490 nm. Every bar in the graph represents at least three
independent experiments (the total concentration of substrate and
product was 1 mM).
FIG. 4. Correlation of the TFAA-NaI test with GC measurements. TOM V106 variants as well as TG1 cells (without an insert, negative control)
were examined by the two methods, using 1 mM methyl phenyl sulfide as a substrate. (a) GC measurements. (b) TFAA-NaI colorimetric
measurements. Readings are normalized to cell density. Results represent averages for duplicates.
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measurements performed in parallel (Fig. 4), indicating that
the tested variants are more active than WT TOM.
(iv) Selective inhibition of HLADH. The assay using HLADH
is a modification of the method described by Sprout and Seto
(28) and is based on the different inhibition constants of (S)-
and (R)-methyl-p-tolyl sulfoxide for the oxidation of ethanol to
acetaldehyde catalyzed by HLADH. The compounds act as
uncompetitive inhibitors, with the (S)-enantiomer being a bet-
ter inhibitor than the (R)-enantiomer. The signal is created by
the accompanying hydrogenation of -NAD to -NADH and
is measured at 340 nm (Fig. 1d). Thus, as (S)-methyl-p-tolyl
sulfoxide concentrations increase, absorption from -NADH
decreases. Following a few preliminary trials, it was discovered
that HLADH is no longer available commercially. An alcohol
dehydrogenase from baker’s yeast was evaluated, but it was not
inhibited by methyl p-tolyl sulfoxide, probably due to a differ-
ent protein structure from that of the horse enzyme. Finally,
crude horse LAP was used successfully in the assay. Various
parameters were examined, such as the pH of the buffer solu-
tion (pH 7 or 8.8), the influence of the presence of sulfide in
the reaction mix, the volume and concentration of LAP, back-
ground provided by other substances in the solution, different
ratios of -NAD and ethanol, various substrate concentrations,
and appropriate durations of the biotransformation and the
enzymatic reaction. It was found that the reaction can be per-
formed in sodium PB, pH 7, which is more suitable for bacte-
rial activity. In addition, it was found that the optimal biotrans-
formation time is 4 h. During this time, product is already
formed and the evaporation of the substrate from the 96-well
plates is negligible. It was also discovered that an appropriate
time for the colorimetric test is 3 h, because during this time
period the enzyme reaches its maximum inhibition and the
color does not change significantly afterwards. It should also be
mentioned that the LAP solution should be filtered prior to
usage.
The applicability of the assay was evaluated using a satura-
tion mutagenesis library of TOM V106, which was previously
screened on methyl phenyl sulfide in our lab (10). The five best
mutants in that study were also evaluated on methyl p-tolyl
sulfide so the results could be compared with the present
screen. Initially, WT TOM, its variants, and TG1/pBS(Kan)
(the host without the enzyme insert was used as a negative
control) were analyzed using the HLADH inhibition-based
assay. In parallel, each sample was injected into a GC (Fig. 5).
The negative control showed the highest absorbance signal,
since no sulfoxide was produced. Mutants with higher activity
and/or selectivity toward the (S)-sulfoxide than that of WT
TOM exhibited lower absorbance due to strong inhibition of
the HLADH. A good correlation between the two methods
was obtained. Afterwards, a total of 700 variants from the
TOM V106 library were screened twice on methyl-p-tolyl sul-
fide. In the second trial, the plates were inverted in order to
neutralize the effect of the variant’s location in the plate. After
summarizing both screenings, the four best-performing mu-
tants and one worst-performing mutant were picked from each
96-well plate and analyzed using GC, making a total of 35
variants (best performing 	 the lowest absorption at 340 nm;
worst performing 	 the highest absorption at 340 nm). Among
the seven worst-performing variants chosen, five were indeed
inactive and two were false negatives. Samples referred to as
false-negative samples are variants that were active according
to GC analysis but showed unexpectedly high absorbance at
340 nm in the screening assay. Among the 28 best-performing
variants chosen, 24 were more enantioselective than the WT
and 25 were more active. Three variants were false-positive
samples, meaning that they were inactive according to GC
analysis but showed low absorbance at 340 nm. These results
represent a success rate of 89% for this assay. Six highly active
and six highly enantioselective variants (according to GC anal-
ysis) were sequenced, and the results were compared to our
previous results (10). The HLADH inhibition assay led to the
selection of one of the most active variants, the V106S mutant,
and one of the most enantioselective variants, the V106A mu-
tant, found in our previous study (10). Two new variants were
discovered (V106N and V106K), since previous screening was
performed on methyl phenyl sulfide and not on methyl p-tolyl
sulfide. According to our results, the use of HLADH inhibition
FIG. 5. Correlation of selective inhibition of HLADH with GC measurements. TG1 cells, TOM, and a few TOM V106 variants were examined
by the two methods, using 1 mM methyl p-tolyl sulfide as a substrate. (a) GC measurements. (b) Selective inhibition of HLADH. Results represent
averages for duplicates.
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enables us to select better variants which are either more
enantioselective, more active, or both.
DISCUSSION
Chiral sulfoxides play a significant role in pharmaceuticals
and in organic synthesis, as functionalized substances and as
important chiral auxiliaries (3, 11, 15). In addition, there is a
growing demand for green catalytic processes (19, 27), and
therefore there is a continuous search for novel and better-
performing biocatalysts. The development of an efficient high-
throughput screening assay for determination of sulfoxide pro-
duction is crucial for the discovery of new or improved
biocatalysts that are able to produce a wide spectrum of sig-
nificant substances (21, 23). Various high-throughput screen-
ing systems are known in the art, but most of them are suitable
for hydrolytic reactions and for isolated enzymes or chemically
synthesized substances (23). A suitable method for measuring
sulfoxide formation or enantioselectivity has not yet been pub-
lished according to our knowledge.
An appropriate screen should be able to detect and quantify
sulfoxides in the presence of sulfides and to be modified to a
96-well format for rapid measurement. The present study de-
scribes four different assays for determination of sulfoxides
produced by whole-cell biocatalysis, including a fluorescence
test for omeprazole, an adrenaline test, a TFAA-NaI test, and
an HLADH inhibition test for methyl p-tolyl sulfoxide deter-
mination. The first three methods determine the production of
sulfoxides, and the fourth method measures the enantiomeric
excess as well as the amount of the sulfoxide produced. Three
of the methods, the fluorescence test for omeprazole, the
TFAA-NaI test, and HLADH inhibition assay, were exploited
for high-throughput screening of TMO libraries and showed
good correlations with HPLC or GC results.
It was previously reported by Morii et al. that acid activation
of omeprazole provides a strong fluorescent signal (18). This
property was used for the development of a high-throughput
screen for determining omeprazole production. During the
optimization of the assay, it was discovered that the fluores-
cence signal is influenced by the ionic strength of the PB. A
high buffer concentration resulted in a strong background sig-
nal which masked the desired sulfoxide signal. Additionally,
the use of LBK as the reaction medium was examined in an
attempt to reduce the workup steps, but the fluorescence signal
was again high and caused a disturbing level of background.
The final screening procedure enabled analysis of several
96-well plates in parallel, and once the acid was added to the
plates, the reaction lasted for only 5 min.
Zhang et al. developed a statistical parameter, the Z factor,
for evaluating high-throughput assays (39). The Z factor, cal-
culated from the positive and negative controls, is a character-
istic parameter for the quality of the assay itself, without the
intervention of the test compounds. If the Z value is small
(negative or close to zero), it usually indicates that the assay
conditions have not been optimized or that the assay format is
not feasible for generating useful data. A value close to 1
implies an excellent assay. The Z factor for the fluorescence
assay for omeprazole was calculated to be 0.89, indicating an
excellent high-throughput assay (39). According to our knowl-
edge, there are no reports on successful biocatalytic oxidation
of omeprazole-sulfide to (S)-omeprazole. Although the screen-
ing of thousands of TMO variants did not result in positive hits
capable of generating (S)-omeprazole, this assay may be of use
for screening other potential oxidizing enzymes.
The adrenaline test for enzyme catalysis, which was devel-
oped by Reymond and coworkers (38), is a versatile high-
throughput assay used for detection of 1,2-diols, 1,2-amino
alcohols, and 
-hydroxyketones by colorimetry. One of its lim-
itations is the fact that periodate reacts with all diol molecules
that might be present in the medium, even the undesirable
ones (13). Consequently, the reaction must be performed in
buffer, and any traces of LBK should be removed. In addition,
the ionic strength of the buffer should be kept low in order to
obtain higher absorbance signals. The present work describes
an attempt to extend the range of this assay for the determi-
nation of sulfoxides by measurement of the remaining sulfide.
The assay was found to be suitable for detection of methyl
phenyl sulfoxide and methyl p-tolyl sulfoxide but not omepra-
zole. However, the sensitivity was not pronounced enough to
allow differentiation between WT TOM and its variants, prob-
ably due to other substances that were secreted by the cells
during biotransformation and oxidized by sodium periodate.
The Z factor calculated for the adrenaline test is 0.18, which
indicates a low sensitivity. Therefore, it can be used only for
determination of the presence or absence of sulfoxides, not to
quantify combinations of sulfides-sulfoxides.
The TFAA-NaI assay was developed initially for the analyt-
ical determination of compounds bearing a semipolar X-O
bond, including a variety of sulfoxides and sulfimides (17). It
exploits inexpensive and commercially available reagents and
provides a visible color change within a short time. This
method was found to be very accurate, reproducible, and suit-
able for detection of various sulfoxides. In addition, the Z
factor calculated for this test is 0.52, which indicates a good
sensitivity. The availability of 96-well polypropylene plates en-
abled this method to be adapted successfully for a high-
throughput format. This method is currently being evaluated in
our lab with other prochiral sulfides.
The use of enzyme inhibition to measure the enantiomeric
excess of a chiral sulfoxide was initially proposed by Sprout and
Seto (28) and was exploited by us as a high-throughput screen-
ing exam for whole-cell biocatalysis of methyl p-tolyl sulfoxide.
In order to demonstrate the high-throughput nature of the
method, about 400 variants were tested in parallel over 3 h.
Similar to other fluorogenic and chromogenic methods for
determination of enantioselective substances, such as assays
for p-nitrophenol chiral esters, the HLADH inhibition test may
be considered a high-throughput assay (21). Moreover, the
calculated Z factor of 0.82 indicates the high quality of this
assay. In addition to its simplicity, this assay is versatile in
nature, since alcohol dehydrogenases from different origins
have different specificities for a wide range of sulfoxides, in-
cluding chiral sulfoxides (8). For example, using (R)- and (S)-
methyl phenyl sulfoxides as inhibitors, the inhibition constants
(Ki) of alcohol dehydrogenase from equine liver are 270 and 33
M, respectively, while the Ki values of Hs-1 class 1 alcohol
dehydrogenase from humans are 1,100 and 1,800 M, respec-
tively (8). In this work, it was also shown that the purity of the
test enzyme is not crucial, as both pure HLADH and crude
LAP worked well. Although only a small library of 700 variants
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was evaluated by this assay, it is expected that 10,000 colonies
may be screened in 2 to 3 weeks, similar to the colorimetric
method described by Bottcher and Bornscheuer for whole cells
expressing esterases (4).
The only drawback of the HLADH inhibition method is the
difficulty in distinguishing between high enantioselectivity (e.g.,
the V106M mutant) (Fig. 5) and a high conversion rate (e.g.,
the V106L mutant) (Fig. 5), since both result in low absorption
measurements (1). Nevertheless, an industrial biocatalyst must
be highly active and enantioselective, and these two properties
are important to detect in a library. This method is currently
being used in our laboratory for evaluation of more random
libraries.
Although chromatography and NMR techniques for high-
throughput screening have been developed in recent years (22,
23), they require expensive equipment, and data analysis is
time-consuming. The methods shown in the present work are
simple and inexpensive and do not require special equipment
besides a multiplate reader.
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